Skip to main content

Table 1 Baseline characteristics of HIV-1 positive participants treated with first-line ART regiments in Jimma, Ethiopia (n =312)

From: Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia

  Women (n =179) Men (n =86) Total (n = 265) Excluded, did not complete 6 months (n =47)
Age, y 31.0 ±8.0 38.0 ±9.0 33.0 ±8.8 32.2
Body mass index (BMI), kg/m2 19.6 ±2.5 19.1 ±1.8 19.4 ±2.3 19.5 ±2.5
CD4 count at enrollment, cells/ul 189 ±113 194 ±113 190.7 ±113 181 ±105
Viral load, log(copies/mL ) 4.7 ±1.0 4.6 ±0.9 4.7 ±1.0 4.8 ±0.9
WHO stage     
Stage I 63 (35.2) 23 (26.7) 86 (32.5) 11 (23.4)
Stage II 47 (26.3) 32 (37.2) 79 (29.8) 12 (25.5)
Stage III 53 (29.6) 26 (30.2) 79 (29.8) 19 (40.4)
Stage IV 16 (8.9) 5 (5.8 ) 21 (7.9) 5 (10.6)
ART regimen     
TDF/3TC/EFV 113 (63.1) 77 (89.5) 190 (71.7) 33 (70.2)
AZT/3TC/EFV 2 (1.1) 1 (1.2) 3 (1.1) 1 (2.1)
TDF/3TC/NVP 27 (15.1) 2 (2.3) 29 (10.9) 3 (5.7)
AZT/3TC/NVP 31 (17.3) 4 (4.7) 35 (13.2) 10 (18.9)
Other* 6 (3.4) 2 (2.3) 8 (3.0) 0 (0.0)
  1. *Other regimen includes mainly D4T and NVP based treatment. Data are mean ±SD or n (%).